NCT06223958Phase 3Active not recruiting

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Study sponsor: Ocular Therapeutix, Inc. · OCUL

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-04-29Estimated
Enrollment · participants344Actual
Source updated2025-04-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview